Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Hematol Oncol. 2018 Dec 5;37(1):96–102. doi: 10.1002/hon.2557

Figure 1. Bone Marrow Blast Response Based on Chromosomal Abnormalities.

Figure 1.

A) Change in BM blasts with lurbinectedin treatment among patients with vs. without chromosome 11q21–23 abnormalities. B) Waterfall plot of change in marrow blasts among patients with and without complex cytogenetics. C) Change in BM blasts with lurbinectedin administration by number of cytogenetic abnormalities. D) Change in PB blasts with lurbinectedin treatment by number of cytogenetic abnormalities.